151 related articles for article (PubMed ID: 19673927)
1. Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia.
Saarinen A; Saukkonen T; Kivelä T; Lahtinen U; Laine C; Somer M; Toiviainen-Salo S; Cole WG; Lehesjoki AE; Mäkitie O
Clin Endocrinol (Oxf); 2010 Apr; 72(4):481-8. PubMed ID: 19673927
[TBL] [Abstract][Full Text] [Related]
2. A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene.
Cheung WM; Jin LY; Smith DK; Cheung PT; Kwan EY; Low L; Kung AW
Bone; 2006 Sep; 39(3):470-6. PubMed ID: 16679074
[TBL] [Abstract][Full Text] [Related]
3. Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men.
Crabbe P; Balemans W; Willaert A; van Pottelbergh I; Cleiren E; Coucke PJ; Ai M; Goemaere S; van Hul W; de Paepe A; Kaufman JM
J Bone Miner Res; 2005 Nov; 20(11):1951-9. PubMed ID: 16234968
[TBL] [Abstract][Full Text] [Related]
4. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women.
Ezura Y; Nakajima T; Urano T; Sudo Y; Kajita M; Yoshida H; Suzuki T; Hosoi T; Inoue S; Shiraki M; Emi M
Bone; 2007 Apr; 40(4):997-1005. PubMed ID: 17306638
[TBL] [Abstract][Full Text] [Related]
5. The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men.
Saarinen A; Välimäki VV; Välimäki MJ; Löyttyniemi E; Auro K; Uusen P; Kuris M; Lehesjoki AE; Mäkitie O
Bone; 2007 Apr; 40(4):1006-12. PubMed ID: 17223614
[TBL] [Abstract][Full Text] [Related]
6. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.
Qin M; Hayashi H; Oshima K; Tahira T; Hayashi K; Kondo H
Hum Mutat; 2005 Aug; 26(2):104-12. PubMed ID: 15981244
[TBL] [Abstract][Full Text] [Related]
7. LRP5 gene polymorphisms and idiopathic osteoporosis in men.
Ferrari SL; Deutsch S; Baudoin C; Cohen-Solal M; Ostertag A; Antonarakis SE; Rizzoli R; de Vernejoul MC
Bone; 2005 Dec; 37(6):770-5. PubMed ID: 16168727
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.
Hartikka H; Mäkitie O; Männikkö M; Doria AS; Daneman A; Cole WG; Ala-Kokko L; Sochett EB
J Bone Miner Res; 2005 May; 20(5):783-9. PubMed ID: 15824851
[TBL] [Abstract][Full Text] [Related]
9. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.
Balemans W; Van Hul W
Endocrinology; 2007 Jun; 148(6):2622-9. PubMed ID: 17395706
[TBL] [Abstract][Full Text] [Related]
10. Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome.
Lev D; Binson I; Foldes AJ; Watemberg N; Lerman-Sagie T
Isr Med Assoc J; 2003 Jun; 5(6):419-21. PubMed ID: 12841014
[TBL] [Abstract][Full Text] [Related]
11. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats.
Chung BD; Kayserili H; Ai M; Freudenberg J; Uzümcü A; Uyguner O; Bartels CF; Höning S; Ramirez A; Hanisch FG; Nürnberg G; Nürnberg P; Warman ML; Wollnik B; Kubisch C; Netzer C
Hum Mutat; 2009 Apr; 30(4):641-8. PubMed ID: 19177549
[TBL] [Abstract][Full Text] [Related]
12. Familial exudative vitreoretinopathy and osteoporosis-pseudoglioma syndrome caused by a mutation in the LRP5 gene.
Drenser KA; Trese MT
Arch Ophthalmol; 2007 Mar; 125(3):431-2. PubMed ID: 17353424
[No Abstract] [Full Text] [Related]
13. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.
Narumi S; Numakura C; Shiihara T; Seiwa C; Nozaki Y; Yamagata T; Momoi MY; Watanabe Y; Yoshino M; Matsuishi T; Nishi E; Kawame H; Akahane T; Nishimura G; Emi M; Hasegawa T
Am J Med Genet A; 2010 Jan; 152A(1):133-40. PubMed ID: 20034086
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the LRP5 gene is associated with osteoporosis-pseudoglioma syndrome.
Barros ER; Dias da Silva MR; Kunii IS; Hauache OM; Lazaretti-Castro M
Osteoporos Int; 2007 Jul; 18(7):1017-8. PubMed ID: 17437160
[No Abstract] [Full Text] [Related]
15. Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density.
Urano T; Shiraki M; Ezura Y; Fujita M; Sekine E; Hoshino S; Hosoi T; Orimo H; Emi M; Ouchi Y; Inoue S
J Bone Miner Metab; 2004; 22(4):341-5. PubMed ID: 15221492
[TBL] [Abstract][Full Text] [Related]
16. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
17. [Wnt-beta-catenin signaling in bone metabolism].
Urano T
Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
[TBL] [Abstract][Full Text] [Related]
18. Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.
Marques-Pinheiro A; Levasseur R; Cormier C; Bonneau J; Boileau C; Varret M; Abifadel M; Allanore Y
Joint Bone Spine; 2010 Mar; 77(2):151-3. PubMed ID: 20096619
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
Ai M; Heeger S; Bartels CF; Schelling DK;
Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
[TBL] [Abstract][Full Text] [Related]
20. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.
Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W
Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
